miRNAs used by HTLV-2 as strategic weapons to prevent HIV-1 replication
Elisabetta Pilotti, C. Casoli(University of Milan), G. Magnani(Istituti di Ricovero e Cura a Carattere Scientifico), F. Bignami(Istituto Superiore di Sanità), Mariolina Gullì(University of Parma), Lucia Lopalco(Vita-Salute San Raffaele University), C Mussini(Azienda Ospedaliero-Universitaria di Modena), Paola Ronzi(University of Milan), Andrea Cossarizza(University of Modena and Reggio Emilia), Roberta Ruotolo(University of Parma), Nelson Marmiroli(University of Parma), Massimo Galli(Luigi Sacco Hospital)
Unknown
January 1, 2011
Cited by 0
Related Papers
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846